Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Neoplasms 4Breast Neoplasms 4Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Lymphatic Metastasis 2Lung Neoplasms 2Head and Neck Neoplasms 2Giant Cell Tumor of Bone 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Solid Tumor 1Sarcoma, Ewing 1Right Hemicolectomy 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Mesothelioma, Malignant 1Melanoma 1Margins of Excision 1Lymphoma 1Inflammatory Breast Neoplasms 1Giant Cell Tumor of Tendon Sheath 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinosarcoma 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Breast Cancer Lymphedema 1

Interventions

Temozolomide 7Vincristine 6Cyclophosphamide 5fludarabine 3Irinotecan 3pegfilgrastim 2irinotecan sucrosofate 2Zoledronic Acid 2Vinorelbine 2Filgrastim 2Dactinomycin 2talazoparib 1silmitasertib 1regorafenib 1pegylated granulocyte colony-stimulating factor 1pazopanib 1liposomal doxorubicin 1fludarabine phosphate 1cabozantinib 1atezolizumab 1amino-acid, glucose, and electrolyte solution 1Whole-Body Irradiation 1Vorinostat 1Tacrolimus 1Radiotherapy 1Mesna 1Melphalan 1Influenza Vaccines 1Indocyanine Green 1Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Rhabdomyosarcoma × Indocyanine Green × Clear all
NCT04084067 2026-04-30

Indocyanine Green (ICG) Guided Tumor Resection

St. Jude Children's Research Hospital

Phase 1 Recruiting
230 enrolled
CNSGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lymphoma, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡